Screening of non-syndromic early-onset child and adolescent obese patients in terms of LEP, LEPR, MC4R and POMC gene variants by next-generation sequencing
Abstract
Objectives
Non-syndromic monogenic obesity is a rare cause of early-onset severe obesity in the childhood period. The aim of this study was to screen four obesity related genes (LEP, LEPR, MC4R and POMC) in children and adolescents who had severe, non-syndromic early onset obesity.
Methods
Next-generation sequencing of all exons in LEP, LEPR, MC4R and POMC was performed in 154 children and adolescents with early onset severe obesity obesity.
Results
Fifteen different variants in nineteen patients were identified with a variant detection rate of 12.3%. While six different heterozygous variants were observed in MC4R gene (10/154 patients; 6.5%), five different variants in POMC gene (four of them were heterozygous and one of them was homozygous) (6/154 patients; 3.9%) and four different homozygous variants in LEPR gene (3/154 patients; 1.9%) were described. However, no variants were detected in the LEP gene. The most common pathogenic variant was c.496G>A in MC4R gene, which was detected in four unrelated patients. Six novel variants (6/15 variants; 40%) were described in seven patients. Four of them including c.233C>A and c.752T>C in MC4R gene and c.761dup and c.1221dup in LEPR gene were evaluated as pathogenic or likely pathogenic.
Conclusions
In conclusion, MC4R variants are the most common genetic cause of monogenic early-onset obesity, consistent with the literature. The c.496G>A variant in MC4R gene is highly prevalent in early-onset obese patients.
Acknowledgments
We would like to thank the children and their parents who participated in this study.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. WPA. A reorientation on obesity. N Engl J Med 1953;248:959–64.10.1056/NEJM195306042482301Search in Google Scholar
2. Thaker, VV. Genetic and epigenetic causes of obesity. Adolesc Med State Art Rev 2017;28:379–405.10.1542/9781581109405-geneticSearch in Google Scholar
3. Huvenne, H, Dubern, B, Clément, K, Poitou, C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obes Facts 2016;9:158–73. https://doi.org/10.1159/000445061.Search in Google Scholar
4. Gale, SM, Castracane, VD, Mantzoros, CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004;134:295–8. https://doi.org/10.1093/jn/134.2.295.Search in Google Scholar
5. Montague, CT, Farooqi, IS, Whitehead, JP, Soos, MA, Rau, H, Wareham, NJ, et al.. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nat 1997;387:903–8. https://doi.org/10.1038/43185.Search in Google Scholar
6. Clement, K, Vaisse, C, Lahlou, N, Cabrol, S, Pelloux, V, Cassuto, D, et al.. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nat 1998;392:398–401. https://doi.org/10.1038/32911.Search in Google Scholar
7. Saeed, S, Bonnefond, A, Manzoor, J, Shabir, F, Ayesha, H, Philippe, J, et al.. Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity 2015;23:1687–95. https://doi.org/10.1002/oby.21142.Search in Google Scholar
8. Paz-Filho, G, Mastronardi, CA, Licinio, J. Leptin treatment: facts and expectations. Metabolism 2015;64:146–56. https://doi.org/10.1016/j.metabol.2014.07.014.Search in Google Scholar
9. Clément, K, van den Akker, E, Argente, J, Bahm, A, Chung, WK, Connors, H, et al.. Setmelanotide POMC and LEPR phase 3 trial investigators. efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol 2020;8:960–70. https://doi.org/10.1016/s2213-8587(20)30364-8.Search in Google Scholar
10. Collet, TH, Dubern, B, Mokrosinski, J, Connors, H, Keogh, JM, Mendes, de, et al.. Evaluation of a melanocortin-4 receptor (MC4R) agonist (setmelanotide) in MC4R deficiency. Mol Metabol 2017;6:1321–9. https://doi.org/10.1016/j.molmet.2017.06.015.Search in Google Scholar PubMed PubMed Central
11. Styne, DM, Arslanian, SA, Connor, EL, Farooqi, IS, Murad, MH, Silverstein, JH, et al.. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017;102:709–57. https://doi.org/10.1210/jc.2016-2573.Search in Google Scholar PubMed PubMed Central
12. Neyzi, O, Bundak, R, Gökçay, G, Günöz, H, Furman, A, Darendeliler, F, et al.. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 2015;7:280–93. https://doi.org/10.4274/jcrpe.2183.Search in Google Scholar PubMed PubMed Central
13. Richards, S, Aziz, N, Bale, S, Bick, D, Das, S, Gastier-Foster, J, et al.. ACMG laboratory quality assurance committee. standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med 2015;17:405–24. https://doi.org/10.1038/gim.2015.30.Search in Google Scholar PubMed PubMed Central
14. Chua, HN, Fan, SH, Say, YH. Prevalence of mdslelanocortin receptor 4 (MC4R) V103I gene variant and its association with obesity among the Kampar Health Clinic cohort, Perak, Malaysia. Med J Malaysia 2012;67:234–5.Search in Google Scholar
15(a). Hinney, A, Volckmar, AL, Knoll, N. Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci 2013;114:147–91.10.1016/B978-0-12-386933-3.00005-4Search in Google Scholar PubMed
(b) Flak, JN, Myers, MG, Minireview: CNS mechanisms of leptin action. Mol Endocrinol 2016;30:3–12.10.1210/me.2015-1232Search in Google Scholar PubMed PubMed Central
16. Cooiman, MI, Kleinendorst, L, Aarts, EO, Janssen, IMC, van Amstel, HKP, Blakemore, AI, et al.. Genetic obesity and bariatric surgery outcome in 1014 patients with morbid obesity. Obes Surg 2019;30:470–7. https://doi.org/10.1007/s11695-019-04184-w.Search in Google Scholar PubMed
17. Santoro, N, Cirillo, G, Xiang, Z, Tanas, R, Greggio, N, Morino, G, et al.. Prevalence of pathogenetic MC4R mutations in Italian children with early onset obesity, tall stature and familial history of obesity. BMC Med Genet 2009;10:25. https://doi.org/10.1186/1471-2350-10-25.Search in Google Scholar PubMed PubMed Central
18. Dubern, B, Clement, K, Pelloux, V, Froguel, P, Girardet, JP, Guy-Grand, B, et al.. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001;139:204–9. https://doi.org/10.1067/mpd.2001.116284.Search in Google Scholar PubMed
19. Polák, E, Vitáriušová, E, Celec, P, Pribilincová, Z, Košťálová, Ľ, Hlavatá, A, et al.. The prevalence of melanocortin-4 receptor gene mutations in slovak obese children and adolescents. J Pediatr Endocrinol Metab 2016;29:55–61. https://doi.org/10.1515/jpem-2015-0015.Search in Google Scholar PubMed
20. Wang, CL, Liang, L, Wang, HJ, Fu, JF, Hebebrand, J, Hinney, A. Several mutations in the melanocortin 4 receptor gene are associated with obesity in chinese children and adolescents. J Endocrinol Invest 2006;29:894–8. https://doi.org/10.1007/bf03349193.Search in Google Scholar PubMed
21. De Rosa, MC, Chesi, A, McCormack, S, Zhou, J, Weaver, B, McDonald, M, et al.. Characterization of rare variants in MC4R in african american and latino children with severe early-onset obesity. J Clin Endocrinol Metab 2019;104:2961–70. https://doi.org/10.1210/jc.2018-02657.Search in Google Scholar
22. Aykut, A, Özen, S, Gökşen, D, Ata, A, Onay, H, Atik, T, et al.. Melanocortin 4 receptor (MC4R) gene variants in children and adolescents having familial early-onset obesity: genetic and clinical characteristics. Eur J Pediatr 2020;179:1445–52. https://doi.org/10.1007/s00431-020-03630-7.Search in Google Scholar
23. Akıncı, A, Türkkahraman, D, Tekedereli, İ, Özer, L, Evren B, Şahin, İ, et al.. Novel mutations in obesity-related genes in turkish children with non-syndromic early onset severe obesity: a multicentre study. J Clin Res Pediatr Endocrinol 2019;11:341–9. https://doi.org/10.4274/jcrpe.galenos.2019.2019.0021.Search in Google Scholar
24. Tunç, S, Demir, K, Tükün, FA, Topal, C, Hazan, F, Sağlam, B, et al.. Melanocortin-4 receptor gene mutations in a group of turkish obese children and adolescents. J Clin Res Pediatr Endocrinol 2017;9:216–21. https://doi.org/10.4274/jcrpe.4225.Search in Google Scholar
25. Tartaglia, LA, Dembski, M, Weng, X, Deng, N, Culpepper, J, Devos, R, et al.. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263–71. https://doi.org/10.1016/0092-8674(95)90151-5.Search in Google Scholar
26. Quinton, ND, Smith, RF, Clayton, PE, Gill, MS, Shalet, S, Justice, SK, et al.. Leptin binding activity changes with age: the link between leptin and puberty. J Clin Endocrinol Metab 1999;84:2336–41. https://doi.org/10.1210/jc.84.7.2336.Search in Google Scholar
27. Niazi, RK, Gjesing, AP, Hollensted, M, Have, CT, Grarup, N, Pedersen, O, et al.. Identification of novel LEPR mutations in Pakistani families with morbid childhood obesity. BMC Med Genet 2018;19:199. https://doi.org/10.1186/s12881-018-0710-x.Search in Google Scholar PubMed PubMed Central
28. Huvenne, H, Le Beyec, J, Pépin, D, Alili, R, Kherchiche, PP, Jeannic E, et al.. Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect. J Clin Endocrinol Metab 2015;100:E757–66. https://doi.org/10.1210/jc.2015-1036.Search in Google Scholar PubMed
29. Farooqi, IS, Wangensteen, T, Collins, S, Kimber, W, Matarese, G, Keogh, JM, et al.. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007;356:237–47. https://doi.org/10.1056/nejmoa063988.Search in Google Scholar
30. Nunziata, A, Funcke, JB, Borck, G, von Schnurbein, J, Brandt, S, Lennerz, B, et al.. Functional and phenotypic characteristics of human leptin receptor mutations. J Endocr Soc 2018;3:27–41. https://doi.org/10.1210/js.2018-00123.Search in Google Scholar PubMed PubMed Central
31. Mazen, I, El-Gammal, M, Abdel-Hamid, M, Farooqi, IS, Amr, K. Homozygosity for a novel missense mutation in the leptin receptor gene (P316T) in two egyptian cousins with severe early onset obesity. Mol Genet Metabol 2011;102:461–4. https://doi.org/10.1016/j.ymgme.2010.12.013.Search in Google Scholar PubMed
32. Saeed, S, Bonnefond, A, Manzoor, J, Philippe, J, Durand, E, Arshad, M, et al.. Novel LEPR mutations in obese Pakistani children identified by PCR-based enrichment and next generation sequencing. Obesity (Silver Spring) 2014;22:1112–7. https://doi.org/10.1002/oby.20667.Search in Google Scholar PubMed
33. Andiran, N, Celik, N, Andiran, F. Homozygosity for two missense mutations in the leptin receptor gene (P316:W646C) in a turkmenian girl with severe early-onset obesity. J Pediatr Endocrinol Metab 2011;24:1043–5.10.1515/JPEM.2011.313Search in Google Scholar
34. Le Beyec, J, Cugnet-Anceau, C, Pépin, D, Alili, R, Cotillard, A, Lacorte, JM, et al.. Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery. J Clin Endocrinol Metab 2013;98:E397–402. https://doi.org/10.1210/jc.2012-2779.Search in Google Scholar PubMed
35. Vauthier, V, Jaillard, S, Journel, H, Dubourg, C, Jockers, R, Dam, J. Homozygous deletion of an 80 kb region comprising part of DNAJC6 and LEPR genes on chromosome 1P31.3 is associated with early onset obesity, mental retardation and epilepsy. Mol Genet Metabol 2012;106:345–50. https://doi.org/10.1016/j.ymgme.2012.04.026.Search in Google Scholar PubMed
36. Saeed, S, Bonnefond, A, Manzoor, J, Shabbir, F, Ayesha, H, Philippe, J, et al.. Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity (Silver Spring) 2015;23:1687–95. https://doi.org/10.1002/oby.21142.Search in Google Scholar PubMed
37. Kleinendorst, L, van Haelst, MM, van den Akker, ELT. Young girl with severe early-onset obesity and hyperphagia. BMJ Case Rep 2017;2017:bcr2017221067.10.1136/bcr-2017-221067Search in Google Scholar PubMed PubMed Central
38. Kakar, N, Ahmad, J, Kubisch, C, Borck, G. Exon skipping and severe childhood-onset obesity caused by a leptin receptor mutation. Am J Med Genet A 2013;161A:2672–4. https://doi.org/10.1002/ajmg.a.36125.Search in Google Scholar PubMed
39. Armağan, C, Yılmaz, C, Koç, A, Abacı, A, Ülgenalp, A, Böber, E, et al.. A toddler with a novel LEPR mutation. Hormones 2019;18:237–40. https://doi.org/10.1007/s42000-019-00097-6.Search in Google Scholar PubMed
40. GBN, N, Busk, ØL, Tveten, K, Hanevik, HI, Fell, AKM, Hjelmesæth, J, et al.. Next-generation sequencing of the monogenic obesity genes LEP, LEPR, MC4R, PCSK1 and POMC in a norwegian cohort of patients with morbid obesity and normal weight controls. Mol Genet Metabol 2017;121:51–6. https://doi.org/10.1016/j.ymgme.2017.03.007.Search in Google Scholar PubMed
41. Krude, H, Biebermann, H, Luck, W, Horn, R, Brabant, G, Grüters, A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155–7. https://doi.org/10.1038/509.Search in Google Scholar PubMed
42. Yaswen, L, Diehl, N, Brennan, MB, Hochgeschwender, U. Obesity in the mouse model of proopiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999;5:1066–70. https://doi.org/10.1038/12506.Search in Google Scholar PubMed
43. Mencarelli, M, Zulian, A, Cancello, R, Alberti, L, Gilardini, L, Di Blasio, AM, et al.. A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity. Eur J Hum Genet 2012;20:1290–4. https://doi.org/10.1038/ejhg.2012.103.Search in Google Scholar PubMed PubMed Central
44. Farooqi, IS, Drop, S, Clements, A, Keogh, JM, Biernacka, J, Lowenbein, S, et al.. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006;55:2549–53. https://doi.org/10.2337/db06-0214.Search in Google Scholar PubMed
45. Miraglia del Giudice, E, Cirillo, G, Santoro, N, D’Urso, L, Carbone, MT, Di Toro, R, et al.. Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord 2001;25:61–7. https://doi.org/10.1038/sj.ijo.0801485.Search in Google Scholar PubMed
46. Challis, BG, Pritchard, LE, Creemers, JW, Delplanque, J, Keogh, JM, Luan, J, et al.. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002;11:1997–2004. https://doi.org/10.1093/hmg/11.17.1997.Search in Google Scholar PubMed
47. Lee, YS, Challis, BG, Thompson, DA, Yeo, GS, Keogh, JM, Madonna, ME, et al.. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metabol 2006;3:135–40. https://doi.org/10.1016/j.cmet.2006.01.006.Search in Google Scholar PubMed
48. Biebermann, H, Castañeda, TR, van Landeghem, F, von Deimling, A, Escher, F, Brabant, G, et al.. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metabol 2006;3:141–6. https://doi.org/10.1016/j.cmet.2006.01.007.Search in Google Scholar PubMed
49. Dubern, B, Lubrano-Berthelier, C, Mencarelli, M, Ersoy, B, Frelut, ML, Bouglé, D, et al.. Mutational analysis of the pro-opiomelanocortin gene in French obese children led to the identification of a novel deleterious heterozygous mutation located in the alpha-melanocyte stimulating hormone domain. Pediatr Res 2008;63:211–6. https://doi.org/10.1203/pdr.0b013e31815ed62b.Search in Google Scholar PubMed
50. Creemers, JW, Lee, YS, Oliver, RL, Bahceci, M, Tuzcu, A, Gokalp, D, et al.. Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. J Clin Endocrinol Metab 2008;93:4494–9. https://doi.org/10.1210/jc.2008-0954.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Article
- Effects of vitamin D supplementation on glycemic control of children and adolescents with type 1 diabetes mellitus: a systematic review
- Original Articles
- A preliminary study on the relationship between environmental endocrine disruptors and precocious puberty in girls
- Tissue concentration of aldosterone in fetal adrenals of intrauterine death cases
- Complications of orthopedic treatment in patients diagnosed with X-linked hypophosphatemic rickets
- Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes
- Evaluation of the growth and nutritional status of preschool children: a pilot study in the cold area of China
- Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity
- From pregnancy to breastfeeding: adequate maternal body mass index is essential to prevent a high body mass index in your children
- Screening of non-syndromic early-onset child and adolescent obese patients in terms of LEP, LEPR, MC4R and POMC gene variants by next-generation sequencing
- The association between vitamin B12, folate, homocysteine levels, and carotid intima-media thickness in children with obesity: a cross-sectional study
- Comprehensive assessment of cardiovascular disease risk in children with short stature due to isolated growth hormone deficiency: a case-control study
- Visceral adiposity is related to insulin sensitivity and inflammation in adolescents with obesity and mild sleep disordered breathing
- Recurrent hypoglycemic seizure as a presenting symptom of post-TBI hypopituitarism in children: a case report, review and proposed protocol
- Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus
- Case Reports
- Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare FGFR3 variant
- Rituximab therapy in ROHHAD(NET) syndrome
- Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab
- A 2-bp deletion mutation in SMPD1 gene leading to lysosomal acid sphingomyelinase deficiency in a Chinese consanguineous pedigree
Articles in the same Issue
- Frontmatter
- Review Article
- Effects of vitamin D supplementation on glycemic control of children and adolescents with type 1 diabetes mellitus: a systematic review
- Original Articles
- A preliminary study on the relationship between environmental endocrine disruptors and precocious puberty in girls
- Tissue concentration of aldosterone in fetal adrenals of intrauterine death cases
- Complications of orthopedic treatment in patients diagnosed with X-linked hypophosphatemic rickets
- Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes
- Evaluation of the growth and nutritional status of preschool children: a pilot study in the cold area of China
- Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity
- From pregnancy to breastfeeding: adequate maternal body mass index is essential to prevent a high body mass index in your children
- Screening of non-syndromic early-onset child and adolescent obese patients in terms of LEP, LEPR, MC4R and POMC gene variants by next-generation sequencing
- The association between vitamin B12, folate, homocysteine levels, and carotid intima-media thickness in children with obesity: a cross-sectional study
- Comprehensive assessment of cardiovascular disease risk in children with short stature due to isolated growth hormone deficiency: a case-control study
- Visceral adiposity is related to insulin sensitivity and inflammation in adolescents with obesity and mild sleep disordered breathing
- Recurrent hypoglycemic seizure as a presenting symptom of post-TBI hypopituitarism in children: a case report, review and proposed protocol
- Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus
- Case Reports
- Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare FGFR3 variant
- Rituximab therapy in ROHHAD(NET) syndrome
- Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab
- A 2-bp deletion mutation in SMPD1 gene leading to lysosomal acid sphingomyelinase deficiency in a Chinese consanguineous pedigree